2022 Q2 Form 10-Q Financial Statement

#000165495422005944 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $277.0K $387.0K $209.0K
YoY Change 8.2% 38.21% -8.33%
% of Gross Profit
Research & Development $951.0K $226.0K $372.0K
YoY Change 301.27% 53.74%
% of Gross Profit
Depreciation & Amortization $8.000K $8.000K $7.000K
YoY Change 14.29% 60.0% 16.67%
% of Gross Profit
Operating Expenses $1.236M $621.0K $588.0K
YoY Change 147.2% 43.75% 55.56%
Operating Profit
YoY Change
Interest Expense -$408.0K $158.0K $220.0K
YoY Change 142.86% -249.06% -204.76%
% of Operating Profit
Other Income/Expense, Net -$455.0K $107.0K -$102.0K
YoY Change 170.83% -211.46% -270.0%
Pretax Income -$1.691M -$514.0K -$470.0K
YoY Change 153.14% -2.65% -11.99%
Income Tax
% Of Pretax Income
Net Earnings -$1.691M -$514.0K -$470.0K
YoY Change 153.14% -2.65% -11.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$26.11K -$8.194K -$7.872K
COMMON SHARES
Basic Shares Outstanding 64.77M shares 58.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $346.9K $1.758M $463.3K
YoY Change -79.42% -77.09% -79.18%
Cash & Equivalents $346.0K $345.0K $462.0K
Short-Term Investments $940.00 $1.413M $1.307K
Other Short-Term Assets $81.00K $317.0K $303.0K
YoY Change -98.05% 1220.83% 1065.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.237M $8.689M $7.159M
YoY Change 4.05% 12.9% -11.06%
LONG-TERM ASSETS
Property, Plant & Equipment $16.48M $16.45M $16.45M
YoY Change 1.83% 4.2% 4.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $165.0K $6.000K $154.0K
YoY Change -14.06% -88.0% 24.19%
Total Long-Term Assets $16.48M $16.45M $16.46M
YoY Change 1.77% 3.91% 4.49%
TOTAL ASSETS
Total Short-Term Assets $7.237M $8.689M $7.159M
Total Long-Term Assets $16.48M $16.45M $16.46M
Total Assets $23.72M $25.14M $23.62M
YoY Change 2.46% 6.85% -0.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $490.0K $230.0K $239.0K
YoY Change 11.87% 67.88% 52.23%
Accrued Expenses $42.00K $37.00K $37.00K
YoY Change 20.0% -2.63% 428.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $532.0K $267.0K $276.0K
YoY Change 12.24% 52.57% 58.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $139.0K $150.0K $160.0K
YoY Change -23.2% -19.79% 28.0%
Total Long-Term Liabilities $139.0K $150.0K $160.0K
YoY Change -23.2% -19.79% 28.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $532.0K $267.0K $276.0K
Total Long-Term Liabilities $139.0K $150.0K $160.0K
Total Liabilities $671.0K $417.0K $436.0K
YoY Change 2.44% 15.19% 45.82%
SHAREHOLDERS EQUITY
Retained Earnings -$52.17M -$49.96M
YoY Change 6.92% 4.97%
Common Stock $648.0K $620.0K
YoY Change 10.96% 6.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.05M $24.72M $23.18M
YoY Change
Total Liabilities & Shareholders Equity $23.72M $25.14M $23.62M
YoY Change 2.46% 6.85% -0.76%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.691M -$514.0K -$470.0K
YoY Change 153.14% -2.65% -11.99%
Depreciation, Depletion And Amortization $8.000K $8.000K $7.000K
YoY Change 14.29% 60.0% 16.67%
Cash From Operating Activities -$675.0K -$597.0K -$434.0K
YoY Change 93.97% 56.28% 47.62%
INVESTING ACTIVITIES
Capital Expenditures -$49.00K -$10.00K -$177.0K
YoY Change -79.58%
Acquisitions
YoY Change
Other Investing Activities $724.0K -$1.552M -$1.185M
YoY Change -269.56% -252.76% -343.83%
Cash From Investing Activities $675.0K -$1.562M -$1.362M
YoY Change -201.2% -253.74% -380.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.023M
YoY Change 1964.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000K $2.042M 1.704M
YoY Change -93.75% 1137.58%
NET CHANGE
Cash From Operating Activities -675.0K -$597.0K -434.0K
Cash From Investing Activities 675.0K -$1.562M -1.362M
Cash From Financing Activities 1.000K $2.042M 1.704M
Net Change In Cash 1.000K -$117.0K -92.00K
YoY Change -100.1% -114.64% -147.92%
FREE CASH FLOW
Cash From Operating Activities -$675.0K -$597.0K -$434.0K
Capital Expenditures -$49.00K -$10.00K -$177.0K
Free Cash Flow -$626.0K -$587.0K -$257.0K
YoY Change 479.63% -12.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64768873 shares
CY2022Q1 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
1000 USD
CY2021Q1 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
3000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
387000 USD
CY2021Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
13000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
621000 USD
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62036399 shares
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8000 USD
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
27000 USD
CY2022Q1 us-gaap Other Income
OtherIncome
0 USD
CY2021Q1 us-gaap Other Income
OtherIncome
10000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25000 USD
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-122000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-96000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-528000 USD
CY2022Q1 sodi Basic And Diluted Per Share
BasicAndDilutedPerShare
-0.01
CY2021Q1 sodi Basic And Diluted Per Share
BasicAndDilutedPerShare
-0.01
CY2022Q1 sodi Weighted Average Basic And Diluted
WeightedAverageBasicAndDiluted
62728000 shares
CY2021Q1 sodi Weighted Average Basic And Diluted
WeightedAverageBasicAndDiluted
58254000 shares
CY2022Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
10000 USD
CY2021Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
10000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-51000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25000 USD
CY2021Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
13000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-597000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-382000 USD
CY2022Q1 sodi Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
1578000 USD
CY2021Q1 sodi Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
-938000 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
78000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
10000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1562000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1016000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2023000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
67000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2042000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-117000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
799000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
462000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
605000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
345000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1404000 USD
CY2022Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50 pure
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">Solitario faces risks related to health epidemics and other outbreaks of communicable diseases, which could significantly disrupt its operations and may materially and adversely affect its business and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">Solitario’s business still could be adversely impacted by the effects of the coronavirus (“COVID-19”) or other epidemics or pandemics.  Solitario has recommended all of its employees and contractors follow government guidelines for health and safety policies for employees and contractors, including encouraging tele-commuting and working from home where possible.  Solitario has evaluated the effects of COVID-19 on its operations and taken pro-active steps to address the impacts on its operations, including at times reducing costs, in response to the economic uncertainty associated with potential risks from COVID-19.  These prior cost reductions included implementing salary reductions and evaluating and reducing certain planned 2021 exploration programs through its joint venture partners at the Florida Canyon and Lik exploration projects.  Also, Solitairo has evaluated the potential impacts on its ability to access future traditional funding sources on the same or reasonably similar terms as in past periods.  Solitario will continue to monitor the effects of COVID-19 on its operations, financial condition and liquidity.  However, the extent to which COVID-19 impacts Solitario’s business, including our exploration and other activities and the market for our securities, will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of any new outbreak and the actions taken to contain or treat the COVID-19 pandemic.  </p>
CY2021Q1 sodi Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
147000 USD
CY2022Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
125000 USD
CY2022Q1 sodi Cash And Cash Equivalents Held In Brokerage Accounts And Foreign Banks
CashAndCashEquivalentsHeldInBrokerageAccountsAndForeignBanks
309000 USD
CY2022Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
6015000 USD
CY2022Q1 sodi Maturities Period Of Current Assets In United States Treasury Securities
MaturitiesPeriodOfCurrentAssetsInUnitedStatesTreasurySecurities
15 days to 19 months
CY2022Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
100000 USD
CY2020Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
250000 USD
CY2022Q1 sodi Certificates Of Deposit Fair Value
CertificatesOfDepositFairValue
599000 USD
CY2022Q1 sodi Maturities Period Of Certificates Of Deposit
MaturitiesPeriodOfCertificatesOfDeposit
one month to nine months
CY2022Q1 sodi Fair Value Of Short Term Investments
FairValueOfShortTermInvestments
51000 USD
CY2021Q1 sodi Fair Value Of Short Term Investments
FairValueOfShortTermInvestments
25000 USD
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5440000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5437650 shares
CY2022Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
16316000 USD
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
16306000 USD
CY2022Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
194000 USD
CY2021Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
125000 USD
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
32000 USD
CY2021Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
22000 USD
CY2022Q1 sodi Exploration Expense Mineral Properties
ExplorationExpenseMineralProperties
226000 USD
CY2022Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1413000 USD
CY2021Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1307000 USD
CY2022Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1597000 USD
CY2021Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1704000 USD
CY2022Q1 sodi Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-184000 USD
CY2021Q4 sodi Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-397000 USD
CY2022Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1413000 USD
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1307000 USD
CY2022Q1 sodi Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
107000 USD
CY2021Q1 sodi Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
65000 USD
CY2022Q1 sodi Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
-81000 USD
CY2021Q1 sodi Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
13000 USD
CY2022Q1 sodi Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-26000 USD
CY2021Q1 sodi Proceeds From The Sale Of Marketable Equity Securities Sold
ProceedsFromTheSaleOfMarketableEquitySecuritiesSold
-78000 USD
CY2022Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
132000 USD
CY2021Q1 us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
-109000 USD
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
106000 USD
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-187000 USD
CY2022Q1 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
213000 USD
CY2021Q1 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
-122000 USD
CY2022Q1 sodi Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
-81000 USD
CY2021Q1 sodi Realized Gain On Marketable Equities Securities Sold
RealizedGainOnMarketableEquitiesSecuritiesSold
13000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
11000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7000 USD
CY2022Q1 sodi Imputed Interest
ImputedInterest
1000 USD
CY2022Q1 sodi Discount Rate
DiscountRate
0.05 pure
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
29000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
36000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
65000 USD
CY2022Q1 us-gaap Interest Portion Of Minimum Lease Payments Sale Leaseback Transactions
InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions
3000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62000 USD
CY2022Q1 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
11000 USD
CY2021Q1 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
7000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
99000 USD
CY2022Q1 sodi Lease And Option Payments For Properties Solitario Owns
LeaseAndOptionPaymentsForPropertiesSolitarioOwns
125000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
136000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
154000 USD
CY2019Q3 us-gaap Marketable Securities
MarketableSecurities
165000 USD
CY2019Q3 us-gaap Guaranty Assets
GuarantyAssets
68000 USD
CY2022Q1 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
1000 USD
CY2021Q1 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
3000 USD
CY2022Q1 sodi Issuance Of Shares Atm Net Value
IssuanceOfSharesAtmNetValue
2023000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
6614000 USD
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
1413000 USD
CY2022Q1 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
2000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
5087000 USD
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
1307000 USD
CY2021Q4 us-gaap Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
3000 USD
CY2022Q1 us-gaap Prepaid Rent
PrepaidRent
65000 USD
CY2022Q1 sodi Description Of Lease
DescriptionOfLease
October of 2023
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
73000 shares
CY2022Q1 sodi Aggregate Intrinsic Value Per Share
AggregateIntrinsicValuePerShare
0.26
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
120350 shares
CY2021Q1 sodi Aggregate Intrinsic Value Per Share
AggregateIntrinsicValuePerShare
0.56
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
67000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
67000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P18Y
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23183000 USD
CY2022Q1 sodi Stock Option Expense
StockOptionExpense
13000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-514000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23502000 USD
CY2021Q1 sodi Stock Option Expense
StockOptionExpense
28000 USD
CY2021Q1 sodi Issuance Of Shares Atm Net Value
IssuanceOfSharesAtmNetValue
98000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
67000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-528000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
23167000 USD
CY2022Q1 sodi Aggregate Purchase Price
AggregatePurchasePrice
2650724 USD
CY2022Q1 sodi Average Price
AveragePrice
0.79
CY2022Q1 sodi Net Proceeds After Expenses
NetProceedsAfterExpenses
2023000000 USD
CY2022Q1 sodi Total Shares Repurchased Shares
TotalSharesRepurchasedShares
994000 shares
CY2022Q1 sodi Total Shares Repurchased
TotalSharesRepurchased
467000 USD

Files In Submission

Name View Source Status
0001654954-22-005944-index-headers.html Edgar Link pending
0001654954-22-005944-index.html Edgar Link pending
0001654954-22-005944.txt Edgar Link pending
0001654954-22-005944-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sodi-20220331.xsd Edgar Link pending
sodi-20220331_cal.xml Edgar Link unprocessable
sodi-20220331_def.xml Edgar Link unprocessable
sodi-20220331_lab.xml Edgar Link unprocessable
sodi-20220331_pre.xml Edgar Link unprocessable
sodi_10q.htm Edgar Link pending
sodi_10q_htm.xml Edgar Link completed
sodi_ex311.htm Edgar Link pending
sodi_ex312.htm Edgar Link pending
sodi_ex321.htm Edgar Link pending